May 15, 2018 02:38 PM EDT
Financing
Startups

Seat­tle's Nohla clos­es $45M to bring nov­el stem cell treat­ment for leukemia to late-stage tri­als

Brittany Meiling

Seat­tle’s Nohla Ther­a­peu­tics, a biotech start­up spun out of the Fred Hutchin­son Can­cer Re­search Cen­ter, has raised $45 mil­lion in new mon­ey to push for­ward …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

The End­points 2024 win­ners and losers list: Who was up and who was down in bio­phar­ma

Up­dat­ed: No­vo’s 23% weight loss with Ca­griSe­ma falls short of high ex­pec­ta­tions, new tri­al planned

FDA ap­proves Hu­ma­cyte’s lab-grown blood ves­sels in mile­stone for re­gen­er­a­tive med­i­cine

Ac­cel­er­at­ed ap­proval brings Pfiz­er's BRAF in­hibitor to first-line pa­tients

Ex­clu­sive: Flori­da can­cer biotech rais­es $100M Se­ries A

Sofinno­va out­lines $550M fund af­ter IPOs and M&A deals

A service from the Financial Times